WeVote

Bill

Bill

H 4490

An Act prohibiting discrimination against 340b drug discount program participants

194th Legislature (2025-2026) Introduced by Dan Cahill and 20 co-sponsors

H 4490 prohibits healthcare providers from facing discrimination for participating in federal 340B drug discount programs that help safety-net hospitals serve low-income patients affordably.

Reporting date extended to Friday, July 31, 2026
0
WeVote Research Nonpartisan
Bill Summary · H 4490

Legislative bill overview

H 4490 prohibits discrimination against participants in the federal 340B drug discount program, which allows covered entities like hospitals and community health centers to purchase medications at significantly reduced prices. The bill would establish protections ensuring these organizations cannot be penalized or denied services based on their participation in the program.

Why is this important

The 340B program serves vulnerable populations by enabling safety-net providers to stretch limited budgets and reinvest savings into patient care. Protecting participants from discrimination ensures these cost-saving benefits reach the communities most dependent on affordable healthcare services.

Potential points of contention

  • Pharmaceutical industry opposition: Drug manufacturers may argue the bill restricts their business practices and ability to manage discount program participation
  • Definition and enforcement scope: Ambiguity about what constitutes "discrimination" and which entities are covered could create compliance challenges
  • Program integrity concerns: Some stakeholders worry protections could enable program abuse or prevent legitimate oversight of discount usage

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.